Oncocyte CorporationOncocyte CorporationOncocyte Corporation

Oncocyte Corporation

No trades
See on Supercharts

OCX fundamentals

Oncocyte Corporation financial statements, including revenue, expenses, profit, and loss

The total revenue of OCX for the last quarter is 314.00 k USD, and it's 26.81% lower compared to the previous quarter. The net income of Q4 23 is -15.99 M USD.

Q1 '22
Q2 '22
Q3 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
‪0.00‬
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: USD
Q1 '22
Q2 '22
Q3 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
TTM
Total revenueYoY growth
Gross profitYoY growth
Pretax incomeYoY growth
Net incomeYoY growth
EBITDAYoY growth
EBITYoY growth